WO1996011267A1 - Adn et proteine a doigts de zinc et leur utilisation - Google Patents
Adn et proteine a doigts de zinc et leur utilisation Download PDFInfo
- Publication number
- WO1996011267A1 WO1996011267A1 PCT/DE1995/001390 DE9501390W WO9611267A1 WO 1996011267 A1 WO1996011267 A1 WO 1996011267A1 DE 9501390 W DE9501390 W DE 9501390W WO 9611267 A1 WO9611267 A1 WO 9611267A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna
- zinc finger
- protein
- finger protein
- nucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Definitions
- Zinc finger DNA, protein and their use relates to a DNA coding for a zinc finger protein and such a protein.
- the invention further relates to the use of the DNA and the protein.
- the conversion of normal cells into tumor cells takes place in several steps, which involve changes in cellular genes or the acquisition of viral oncogenes. Changes in cellular genes include the activation of proto-oncogenes by mutation, gene amplification, overexpression or chromosome translocations as well as the inactivation of tumor suppressor genes by mutation or deletion.
- genes the changes of which are important in the development of tumors, have so far been identified (cf. review article: Bishop, J.M., Cell 64 (1 991), 235-248).
- the products of such genes have different functions. They work e.g. as transcription regulators, as links in different signal transduction chains, such as growth factors, growth factor receptors or protein kinases, or as activators or inhibitors of cell division.
- transcription regulators are zinc finger proteins. These proteins have characteristic structures containing two cysteine and two histidine residues which are positioned relative to one another in such a way that they bind a zinc atom. Zinc finger proteins are DNA-binding proteins. An example of zinc finger proteins is the product of the Wilms tumor suppressor gene WT1, the loss of which plays an important role in the development of Wilms kidney tumors.
- the present invention is therefore based on the object of providing a means with which tumor diagnosis and therapy can be carried out more comprehensively.
- the invention thus relates to a DNA coding for a zinc finger protein, which comprises:
- hybridizing DNA indicates a DNA which hybridizes with a DNA of (a) under customary conditions, in particular at 20 ° C. below the melting point of the DNA.
- FIG. 1 shows the insert of the cDNA clone COS AP4-E1.
- This clone comes from a cDNA library of the cervical carcinoma cell line ME 180 (cf. Reuter, M.S. et al., J. Virol. 65 (1991), 5564-5568).
- This cell line contains the human papillomavirus 68-DNA (HPV 68-DNA) stably integrated.
- the clone COS AP4-E1 contains HPV 68 DNA between nucleotides 1-21. It also contains cellular sequences between nucleotides 22-1476, these being exon sequences of a zinc finger gene between nucleotides 446-1476.
- the exon sequences code for 4 zinc fingers zinc finger 1: 1130-1 191, zinc finger 2: 1214-1275, zinc finger 3: 1298-1360, zinc finger 4: 1382-1432.
- the clone COS AP4-E1 was deposited with the DSM (German Collection of Microorganisms and Cell Cultures under DSM 9450 on September 30, 1994).
- the above insert DNA can be part of a DNA coding for a complete zinc finger protein.
- Such a DNA and the zinc finger protein encoded by it are thus also the subject of the invention.
- the insert DNA from COS AP4-E1 in particular the DNA between nucleotides 446-1476
- a cDNA library from blood cells or HeLa cells can also be used.
- the tissues and cells mentioned contain sufficient RNA transcripts that hybridize with the insert DNA from COS AP4-E1, in particular the DNA between nucleotides 446-1476 (cf. FIG. 2). Clones obtained are subjected to sequencing and, starting from the insert DNA of COS AP4-E1, in particular the DNA between nucleotides 446-1476, the DNA coding for a zinc finger protein above is determined.
- the insert DNA from COS AP4-E1 in particular the DNA between nucleotides 446-1476, and very particularly the DNA between nucleotides 1240-1476, is suitable for identifying a genomic DNA coding for the above zinc finger protein.
- the corresponding DNA from COS AP4-E1 e.g. the DNA between the nucleotides 1240-1476, used as a probe for hybridizing a genomic DNA library.
- Such can be created from the tissues and cells mentioned above.
- the clone COS 1 APM is obtained. Its insert DNA contains in a 5.5 kb Sacl fragment the probe used, e.g. DNA corresponding to DNA between nucleotides 1240-1476. In Figures 3 and 4 this DNA from COS 1 APM is presented between nucleotides 256-492.
- the clone COS 1 APM was deposited with the DSM under DSM 9462 on October 7, 1994. The invention thus also relates to a genomic DNA encoding the above zinc finger protein and the protein encoded by it.
- the DNA coding for the zinc finger protein can be present in a vector or expression vector.
- a vector or expression vector examples of such are known to the person skilled in the art.
- these are, for example, pGE-MEX, pUC derivatives and pGEX-2T.
- yeast for example, pY100 and Ycpadl should be mentioned, while for expression in animal cells, for example, pKCR, pEF- BOS, cDM8 and pCEV4 must be specified.
- suitable cells in order to express the above DNA present in an expression vector examples of such cells include the E.
- the person skilled in the art knows how the above DNA has to be inserted into an expression vector. He is also aware that the above cDNA can be expressed in E. coli, yeast or animal cells, whereas the above genomic DNA is only to be expressed in animal cells. Furthermore, the person skilled in the art knows the conditions for cultivating transformed or transfected cells. He is also familiar with methods of isolating and purifying the expressed zinc finger protein. An above, recombinantly produced zinc finger protein is therefore also the subject of the invention.
- Another object of the invention is an antibody directed against an above zinc finger protein.
- Such is produced in the usual way.
- the zinc finger protein is injected subcutaneously into BALB / c mice. This injection is repeated every 3 weeks. About 2 weeks after the last injection, the serum containing the antibody is isolated and tested in the usual way.
- the antibody is a monoclonal antibody.
- spleen cells are removed from the mice after the fourth injection above and these are fused with myeloma cells in the usual way. The further cloning is also carried out according to known methods.
- the present invention provides a previously unknown zinc finger DNA and a zinc finger protein encoded by it.
- the DNA according to the invention is suitable as a probe for diagnostic purposes.
- it can be used for gene therapy in an expression vector known to those skilled in the art.
- the protein according to the invention is also suitable for therapeutic purposes. For this purpose, it can be administered in a customary pharmaceutical composition.
- the present invention further provides antibodies directed against the above protein. These are ideal for diagnostic purposes.
- the present invention thus provides new means for the diagnosis and therapy of diseases related to the DNA according to the invention and the protein encoded by them, in particular tumor diseases.
- FIG. 2 shows the hybridization of polyA + RNA from different cells with the DNA between nucleotides 1240-1476 of COS AP4-E1
- FIG. 3 shows a partial sequence of the genomic insert DNA of the clone COS 1
- FIG. 4 shows the comparison of the DNA between nucleotides 1240-1476 of clone COS AP4-E1 and the DNA between nucleotides 256-
- the invention is illustrated by the following example.
- a ⁇ cDNA library created from HeLa cells is subjected to a conventional hybridization process.
- the phage plaques obtained by infection of the bacteria are incubated with the 32 p-labeled DNA insert of the clone COS AP4-E1, in particular the DNA between the nucleotides 1240-1476 (cf. FIG. 1). Hybridization with individual phage plaques is obtained.
- the phage DNA is isolated from these and cleaved with EcoRI.
- the fragments obtained are separated electrophoretically in a 0.5% agarose gel.
- the agarose gel is subjected to a conventional blotting process, whereby the DNA from the agarose gel is transferred to a nitrocellulose membrane.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8512260A JPH10506789A (ja) | 1994-10-07 | 1995-10-06 | 亜鉛フィンガー蛋白質をコードするdna、亜鉛フィンガー蛋白質およびそれらの使用 |
EP95935327A EP0784680A1 (fr) | 1994-10-07 | 1995-10-06 | Adn et proteine a doigts de zinc et leur utilisation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4435919.5 | 1994-10-07 | ||
DE4435919A DE4435919C1 (de) | 1994-10-07 | 1994-10-07 | Zinkfinger-DNA, -Protein und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996011267A1 true WO1996011267A1 (fr) | 1996-04-18 |
Family
ID=6530235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1995/001390 WO1996011267A1 (fr) | 1994-10-07 | 1995-10-06 | Adn et proteine a doigts de zinc et leur utilisation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0784680A1 (fr) |
JP (1) | JPH10506789A (fr) |
DE (1) | DE4435919C1 (fr) |
WO (1) | WO1996011267A1 (fr) |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021991A1 (fr) * | 1997-10-29 | 1999-05-06 | Shanghai Second Medical University | Bmzf12: gene a doigt de zinc clone a partir de la moelle osseuse |
WO1999046293A1 (fr) * | 1998-03-12 | 1999-09-16 | Shanghai Second Medical University | Proteine a doigt de zinc derivee de cellules hematopoietiques |
WO2001066580A1 (fr) * | 2000-03-07 | 2001-09-13 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine humaine 13 a doigt de zinc, et polynucleotide codant pour ce polypeptide |
WO2001066582A1 (fr) * | 2000-03-10 | 2001-09-13 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 27, et polynucleotide codant pour ce polypeptide |
WO2001066583A1 (fr) * | 2000-03-10 | 2001-09-13 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine 14 a doigt de zinc, et polynucleotide codant pour ce polypeptide |
WO2001068690A1 (fr) * | 2000-03-15 | 2001-09-20 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 15, et polynucleotide codant pour ce polypeptide |
WO2001072803A1 (fr) * | 2000-03-28 | 2001-10-04 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 15, et polynucleotide codant pour ce polypeptide |
WO2001074868A1 (fr) * | 2000-03-07 | 2001-10-11 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine humaine a doigt de zinc 10, et polynucleotide codant pour ce polypeptide |
WO2001074882A1 (fr) * | 2000-03-28 | 2001-10-11 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 49, et polynucleotide codant pour ce polypeptide |
WO2001074993A2 (fr) * | 2000-03-10 | 2001-10-11 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide |
WO2001074865A1 (fr) * | 2000-03-15 | 2001-10-11 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine a doigt de zinc 10, et polynucleotide codant pour ce polypeptide |
WO2001074866A1 (fr) * | 2000-03-02 | 2001-10-11 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, protéine humaine a doigt de zinc 72, et polynucléotide codant pour ce polypeptide |
WO2001094397A1 (fr) * | 2000-06-07 | 2001-12-13 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine a doigt de zinc 79.46, et polynucleotide codant ce polypeptide |
WO2002004500A1 (fr) * | 2000-06-19 | 2002-01-17 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine humaine a doigt de zinc fpm315-17, et polynucleotide codant ce polypeptide |
WO2002004502A1 (fr) * | 2000-06-19 | 2002-01-17 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine murine a doigt de zinc 16 (zfp-1), et polynucleotide codant ce polypeptide |
WO2002010211A1 (fr) * | 2000-06-30 | 2002-02-07 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 12.98, et polynucleotide codant ce polypeptide |
WO2002020600A1 (fr) * | 2000-06-28 | 2002-03-14 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 10.45, et polynucleotide codant ce polypeptide |
US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
US6479626B1 (en) | 1998-03-02 | 2002-11-12 | Massachusetts Institute Of Technology | Poly zinc finger proteins with improved linkers |
US6503717B2 (en) | 1999-12-06 | 2003-01-07 | Sangamo Biosciences, Inc. | Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US6599692B1 (en) | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
US6733970B2 (en) | 1998-11-09 | 2004-05-11 | Gendaq Limited | Screening system for zinc finger polypeptides for a desired binding ability |
US6746838B1 (en) | 1997-05-23 | 2004-06-08 | Gendaq Limited | Nucleic acid binding proteins |
US6790941B2 (en) | 1994-01-18 | 2004-09-14 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
US6794136B1 (en) | 2000-11-20 | 2004-09-21 | Sangamo Biosciences, Inc. | Iterative optimization in the design of binding proteins |
US6977154B1 (en) | 1998-03-17 | 2005-12-20 | Gendaq Limited | Nucleic acid binding proteins |
US7013219B2 (en) | 1999-01-12 | 2006-03-14 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US7026462B2 (en) | 2000-12-07 | 2006-04-11 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
US7030215B2 (en) | 1999-03-24 | 2006-04-18 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US7067317B2 (en) | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
US7070934B2 (en) | 1999-01-12 | 2006-07-04 | Sangamo Biosciences, Inc. | Ligand-controlled regulation of endogenous gene expression |
USRE39229E1 (en) | 1994-08-20 | 2006-08-08 | Gendaq Limited | Binding proteins for recognition of DNA |
US7262054B2 (en) | 2002-01-22 | 2007-08-28 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
US7273923B2 (en) | 2001-01-22 | 2007-09-25 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
US7361635B2 (en) | 2002-08-29 | 2008-04-22 | Sangamo Biosciences, Inc. | Simultaneous modulation of multiple genes |
US7585849B2 (en) | 1999-03-24 | 2009-09-08 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US7851216B2 (en) | 2000-01-24 | 2010-12-14 | Gendaq, Ltd. | Methods and compositions for linking binding domains in nucleic acid binding proteins |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0825198A1 (fr) * | 1996-08-22 | 1998-02-25 | K.U. Leuven Research & Development | Famille de gènes Plag et tumorigénèse |
WO1999062951A1 (fr) * | 1998-06-04 | 1999-12-09 | Shanghai Second Medical University | Gene humain de proteine a doigts de zinc (bmzf3) |
CA2702148C (fr) * | 1999-01-06 | 2014-03-04 | Genenews Inc. | Methode de profilage de l'expression genique d'un sujet humain atteint d'une maladie infectieuse |
US7473528B2 (en) | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
CN1328040A (zh) * | 2000-06-12 | 2001-12-26 | 上海博德基因开发有限公司 | 一种新的多肽——人锌指蛋白18.04和编码这种多肽的多核苷酸 |
CN1331219A (zh) * | 2000-06-30 | 2002-01-16 | 上海博德基因开发有限公司 | 一种新的多肽——人锌指蛋白18.92和编码这种多肽的多核苷酸 |
SI1385882T1 (sl) | 2001-05-11 | 2008-04-30 | Amgen Inc | Peptidi in sorodne molekule, ki se vežejo na tall-1 |
PH12022550138A1 (en) | 2013-03-13 | 2023-03-06 | Amgen Inc | Proteins specific for baff and b7rp1 and uses thereof |
US9458246B2 (en) | 2013-03-13 | 2016-10-04 | Amgen Inc. | Proteins specific for BAFF and B7RP1 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0449170A1 (fr) * | 1990-03-30 | 1991-10-02 | BEHRINGWERKE Aktiengesellschaft | Protéine d'attachement cellulaire ayant une affinité pour la région régulatrice du papilloma virus humain de type 18 |
-
1994
- 1994-10-07 DE DE4435919A patent/DE4435919C1/de not_active Expired - Fee Related
-
1995
- 1995-10-06 JP JP8512260A patent/JPH10506789A/ja active Pending
- 1995-10-06 WO PCT/DE1995/001390 patent/WO1996011267A1/fr not_active Application Discontinuation
- 1995-10-06 EP EP95935327A patent/EP0784680A1/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0449170A1 (fr) * | 1990-03-30 | 1991-10-02 | BEHRINGWERKE Aktiengesellschaft | Protéine d'attachement cellulaire ayant une affinité pour la région régulatrice du papilloma virus humain de type 18 |
Non-Patent Citations (3)
Title |
---|
GALERA ET AL.: "c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin", PROC. NATL ACAD. SCI., vol. 91, no. 20, 27 September 1994 (1994-09-27), pages 9372 - 9376 * |
OLGIVIE ET AL.: "Sequence divergence of a TFIIIA-type zinc finger protein from fish ovarian tissue", NUCLEIC ACIDS RES., vol. 21, no. 17, pages 4152 * |
REUTER ET AL.: "Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180", J. VIROLOGY, vol. 65, no. 10, pages 5564 - 5568 * |
Cited By (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6790941B2 (en) | 1994-01-18 | 2004-09-14 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
USRE42211E1 (en) | 1994-08-20 | 2011-03-08 | Gendaq, Limited | Relating to binding proteins for recognition of DNA |
USRE39229E1 (en) | 1994-08-20 | 2006-08-08 | Gendaq Limited | Binding proteins for recognition of DNA |
USRE45795E1 (en) | 1994-08-20 | 2015-11-10 | Gendaq, Ltd. | Binding proteins for recognition of DNA |
USRE45721E1 (en) | 1994-08-20 | 2015-10-06 | Gendaq, Ltd. | Relating to binding proteins for recognition of DNA |
USRE42150E1 (en) | 1994-08-20 | 2011-02-15 | Gendaq, Limited | Binding proteins for recognition of DNA |
US7759059B2 (en) | 1997-05-23 | 2010-07-20 | Gendaq Limited, C/O Brobeck Hale And Dorr | Nucleic acid binding proteins |
US6866997B1 (en) | 1997-05-23 | 2005-03-15 | Gendaq Limited | Nucleic acid binding proteins |
US8617807B2 (en) | 1997-05-23 | 2013-12-31 | Gendaq Limited | Nucleic acid binding proteins |
US7241574B2 (en) | 1997-05-23 | 2007-07-10 | Gendaq Ltd. | Nucleic acid binding proteins |
US6746838B1 (en) | 1997-05-23 | 2004-06-08 | Gendaq Limited | Nucleic acid binding proteins |
WO1999021991A1 (fr) * | 1997-10-29 | 1999-05-06 | Shanghai Second Medical University | Bmzf12: gene a doigt de zinc clone a partir de la moelle osseuse |
US7928195B2 (en) | 1998-03-02 | 2011-04-19 | Massachusetts Institute Of Technology | Poly zinc finger proteins with improved linkers |
US6479626B1 (en) | 1998-03-02 | 2002-11-12 | Massachusetts Institute Of Technology | Poly zinc finger proteins with improved linkers |
US7595376B2 (en) | 1998-03-02 | 2009-09-29 | Massachusetts Institute Of Technology | Poly zinc finger proteins with improved linkers |
US7153949B2 (en) | 1998-03-02 | 2006-12-26 | Massachusetts Institute Of Technology | Nucleic acid encoding poly-zinc finger proteins with improved linkers |
WO1999046293A1 (fr) * | 1998-03-12 | 1999-09-16 | Shanghai Second Medical University | Proteine a doigt de zinc derivee de cellules hematopoietiques |
US6977154B1 (en) | 1998-03-17 | 2005-12-20 | Gendaq Limited | Nucleic acid binding proteins |
US6733970B2 (en) | 1998-11-09 | 2004-05-11 | Gendaq Limited | Screening system for zinc finger polypeptides for a desired binding ability |
US7163824B2 (en) | 1999-01-12 | 2007-01-16 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US7177766B2 (en) | 1999-01-12 | 2007-02-13 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
US6607882B1 (en) | 1999-01-12 | 2003-08-19 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US7013219B2 (en) | 1999-01-12 | 2006-03-14 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US7220719B2 (en) | 1999-01-12 | 2007-05-22 | Sangamo Biosciences, Inc. | Modulation of endogenous gene expression in cells |
US7070934B2 (en) | 1999-01-12 | 2006-07-04 | Sangamo Biosciences, Inc. | Ligand-controlled regulation of endogenous gene expression |
US6785613B2 (en) | 1999-01-12 | 2004-08-31 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
US7788044B2 (en) | 1999-01-12 | 2010-08-31 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
US7985887B2 (en) | 1999-01-12 | 2011-07-26 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US6824978B1 (en) | 1999-01-12 | 2004-11-30 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US8268618B2 (en) | 1999-01-12 | 2012-09-18 | Sangamo Biosciences, Inc. | Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins |
US6933113B2 (en) | 1999-01-12 | 2005-08-23 | Sangamo Biosciences, Inc. | Modulation of endogenous gene expression in cells |
US9491934B2 (en) | 1999-01-12 | 2016-11-15 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US6979539B2 (en) | 1999-01-12 | 2005-12-27 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US7030215B2 (en) | 1999-03-24 | 2006-04-18 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US7585849B2 (en) | 1999-03-24 | 2009-09-08 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US8383766B2 (en) | 1999-03-24 | 2013-02-26 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US8524874B2 (en) | 1999-03-24 | 2013-09-03 | Sangamo Biosciences | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US7235354B2 (en) | 1999-09-14 | 2007-06-26 | Sangamo Biosciences, Inc. | Functional genomics using zinc finger proteins |
US6777185B2 (en) | 1999-09-14 | 2004-08-17 | Sangamo Biosciences, Inc. | Functional genomics using zinc finger proteins |
US6599692B1 (en) | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
US6503717B2 (en) | 1999-12-06 | 2003-01-07 | Sangamo Biosciences, Inc. | Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
US7491531B2 (en) | 1999-12-06 | 2009-02-17 | Sangamo Biosciences, Inc. | Randomized libraries of zinc finger proteins |
US7943553B2 (en) | 1999-12-06 | 2011-05-17 | Sangamo Biosciences, Inc. | Randomized libraries of zinc finger proteins |
US7851216B2 (en) | 2000-01-24 | 2010-12-14 | Gendaq, Ltd. | Methods and compositions for linking binding domains in nucleic acid binding proteins |
WO2001074866A1 (fr) * | 2000-03-02 | 2001-10-11 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, protéine humaine a doigt de zinc 72, et polynucléotide codant pour ce polypeptide |
WO2001074868A1 (fr) * | 2000-03-07 | 2001-10-11 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine humaine a doigt de zinc 10, et polynucleotide codant pour ce polypeptide |
WO2001066580A1 (fr) * | 2000-03-07 | 2001-09-13 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine humaine 13 a doigt de zinc, et polynucleotide codant pour ce polypeptide |
WO2001066583A1 (fr) * | 2000-03-10 | 2001-09-13 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine 14 a doigt de zinc, et polynucleotide codant pour ce polypeptide |
WO2001066582A1 (fr) * | 2000-03-10 | 2001-09-13 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 27, et polynucleotide codant pour ce polypeptide |
WO2001074993A3 (fr) * | 2000-03-10 | 2002-11-28 | Shanghai Biowindow Gene Dev | Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide |
WO2001074993A2 (fr) * | 2000-03-10 | 2001-10-11 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide |
WO2001074865A1 (fr) * | 2000-03-15 | 2001-10-11 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine a doigt de zinc 10, et polynucleotide codant pour ce polypeptide |
WO2001068690A1 (fr) * | 2000-03-15 | 2001-09-20 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 15, et polynucleotide codant pour ce polypeptide |
WO2001072803A1 (fr) * | 2000-03-28 | 2001-10-04 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 15, et polynucleotide codant pour ce polypeptide |
WO2001074882A1 (fr) * | 2000-03-28 | 2001-10-11 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 49, et polynucleotide codant pour ce polypeptide |
WO2001094397A1 (fr) * | 2000-06-07 | 2001-12-13 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine a doigt de zinc 79.46, et polynucleotide codant ce polypeptide |
WO2002004502A1 (fr) * | 2000-06-19 | 2002-01-17 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine murine a doigt de zinc 16 (zfp-1), et polynucleotide codant ce polypeptide |
WO2002004500A1 (fr) * | 2000-06-19 | 2002-01-17 | Biowindow Gene Development Inc. Shanghai | Nouveau polypeptide, proteine humaine a doigt de zinc fpm315-17, et polynucleotide codant ce polypeptide |
WO2002020600A1 (fr) * | 2000-06-28 | 2002-03-14 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 10.45, et polynucleotide codant ce polypeptide |
WO2002010211A1 (fr) * | 2000-06-30 | 2002-02-07 | Shanghai Biowindow Gene Development Inc. | Nouveau polypeptide, proteine humaine a doigt de zinc 12.98, et polynucleotide codant ce polypeptide |
US6794136B1 (en) | 2000-11-20 | 2004-09-21 | Sangamo Biosciences, Inc. | Iterative optimization in the design of binding proteins |
US7560440B2 (en) | 2000-12-07 | 2009-07-14 | Sangamo Bioschiences, Inc. | Regulation of angiogenesis with zinc finger proteins |
US7026462B2 (en) | 2000-12-07 | 2006-04-11 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
US8071564B2 (en) | 2000-12-07 | 2011-12-06 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
US7067317B2 (en) | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
US7605140B2 (en) | 2000-12-07 | 2009-10-20 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
US9234187B2 (en) | 2001-01-22 | 2016-01-12 | Sangamo Biosciences, Inc. | Modified zinc finger binding proteins |
US8680021B2 (en) | 2001-01-22 | 2014-03-25 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
US7273923B2 (en) | 2001-01-22 | 2007-09-25 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
US9234188B2 (en) | 2001-01-22 | 2016-01-12 | Sangamo Biosciences, Inc. | Modified zinc finger binding proteins |
US9238803B2 (en) | 2001-01-22 | 2016-01-19 | Sangamo Biosciences, Inc. | Modified zinc finger binding proteins |
US7705139B2 (en) | 2001-01-22 | 2010-04-27 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
US10344271B2 (en) | 2001-01-22 | 2019-07-09 | Sangamo Therapeutics, Inc. | Modified zinc finger binding proteins |
US7262054B2 (en) | 2002-01-22 | 2007-08-28 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
US7939327B2 (en) | 2002-08-29 | 2011-05-10 | Sangamo Biosciences, Inc. | Simultaneous modulation of multiple genes |
US7361635B2 (en) | 2002-08-29 | 2008-04-22 | Sangamo Biosciences, Inc. | Simultaneous modulation of multiple genes |
Also Published As
Publication number | Publication date |
---|---|
JPH10506789A (ja) | 1998-07-07 |
EP0784680A1 (fr) | 1997-07-23 |
DE4435919C1 (de) | 1995-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4435919C1 (de) | Zinkfinger-DNA, -Protein und ihre Verwendung | |
DE3752360T2 (de) | Menschliche DNS zum Nachweis von Retinoblastoma | |
DE69014162T2 (de) | Morphogenetisches Knochenprotein. | |
EP0517024B1 (fr) | Récepteurs tétravalents bispécifiques, leur préparation et utilisation | |
DE69431736T2 (de) | Neues Chemokine von hematopoietischen Zellen produziert und die dafür kodierende DNA | |
DE69435038T2 (de) | Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie | |
WO1995003328A2 (fr) | Proteine d'inhibition de melanomes | |
WO1997023611A2 (fr) | Sequences d'acide nucleique de genes des proteines du groupe a grande mobilite et leurs utilisations | |
DE4415743C2 (de) | Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen | |
DE19526386C1 (de) | Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen | |
DE69836278T2 (de) | Allele formen von menschlichem stat3 | |
DE69728436T9 (de) | Leptin-protein aus schwein, dafür kodierende nukleinsäuren und verwendungen davon | |
DE19648962C1 (de) | Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen | |
DE69022165T2 (de) | Klonierungs-Plasmid-Vektor, Primer-Vektor davon und Herstellungsverfahren einer cDNA-Bank. | |
DE69838565T2 (de) | Nukleinsäuren von CIITA Genen | |
EP1007671B1 (fr) | Gene ii de fanconi | |
EP0941369B1 (fr) | Adn permettant d'evaluer le potentiel de progression de lesions du col de l'uterus | |
EP1003877A2 (fr) | Papillomavirus, agents permettant de les mettre en evidence et de traiter des affections induites par lesdits papillomavirus | |
DE19613606C1 (de) | Gen für Hypertonie | |
DE69834951T2 (de) | Eine familie von genen mit transformationsmodulierender aktivität | |
EP0972047A2 (fr) | Proteines a capside principale de papillomavirus et leur utilisation a des fins de diagnostic, de therapie et de vaccination | |
WO1993013205A1 (fr) | Gene regulateur associe au neuroblastome | |
DE19816186A1 (de) | GDNF-kodierende DNA, Teile davon und GDNF-Varianten | |
EP1214398B1 (fr) | Particules chimeriques analogues a des virus et capsomeres chimeriques de papillomavirus bovin | |
DE19812375C1 (de) | Für Tumorsuppressorproteine codierende Nucleinsäure, Tumorsuppressorproteine, Verfahren zu deren Herstellung, Antikörper gegen Tumorsuppressorproteine und Verwendung dieser Gegenstände |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT.BUL.17/96 UNDER INID(51)"IPC",REPLACE"A01K 38/17"BY"A61K 38/17" |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1997 836014 Date of ref document: 19970407 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995935327 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1995935327 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995935327 Country of ref document: EP |